Close Menu

Creative commons licensing is in the air -- or at least in the blogosphere. A few blogs have written about licensing data or even your genome recently. Deepak Singh at BBGM contends that all "data needs to be licensed in some form, even if it’s open," though he acknowledges that while licensing data from papers is pretty straightforward, he's not sure how scientists would deal with the source data, such as "intensities from a microarray experiment."

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.